Loading
Loading
Ligand Pharmaceuticals ceo salary
Todd C. Davis, Chief Executive Officer of LIGAND PHARMACEUTICALS INC (LGND), received $11,472,095 ($11.5M) in total compensation for FY2025, down 11.2% from the prior year. Stock awards of $5,520,493 were the largest component. Figures come from LIGAND PHARMACEUTICALS INC's DEF 14A filed 21 Apr 2026 (accession 0000886163-26-000021).
Reported total from the latest DEF 14A pay table. Source filing (accession 0000886163-26-000021). These figures come from LIGAND PHARMACEUTICALS INC's DEF 14A filed 21 Apr 2026 (accession 0000886163-26-000021).
| Component | Amount |
|---|---|
| Salary | $724,500 |
| Stock awards | $5,520,493 |
| Option awards | $4,441,120 |
| Cash incentive | $764,400 |
| Other | $21,582 |
| Total | $11,472,095 |
FAQ
See also: LGND ticker page